Bamias AT - Search Results

1

Prognostic significance of the deleted in colorectal cancer gene protein expression in high-risk resected gastric carcinoma.

Bamias AT, Bai MC, Agnantis NJ, Michael MC, Alamanos YP, Stefanaki SV, Razi ED, Skarlos DV, Kappas AM, Pavlidis NA. Bamias AT, et al. Cancer Invest. 2003 Jun;21(3):333-40. doi: 10.1081/cnv-120018219. Cancer Invest. 2003. PMID: 12901278

2

Prognostic factors in patients with colorectal cancer receiving adjuvant chemotherapy or chemoradiotherapy: a pooled analysis of two randomized studies.

Bamias A, Basdanis G, Xanthakis I, Pavlidis N, Fountzilas G. Bamias A, et al. Int J Gastrointest Cancer. 2005;36(1):29-38. doi: 10.1385/IJGC:36:1:029. Int J Gastrointest Cancer. 2005. PMID: 16227633

3

Endobronchial metastases secondary to solid tumors: report of eight cases and review of the literature.

Katsimbri PP, Bamias AT, Froudarakis ME, Peponis IA, Constantopoulos SH, Pavlidis NA. Katsimbri PP, et al. Among authors: bamias at. Lung Cancer. 2000 May;28(2):163-70. doi: 10.1016/s0169-5002(99)00134-8. Lung Cancer. 2000. PMID: 10717334 Review.

4

The combination of gemcitabine and carboplatin as first-line treatment in patients with advanced urothelial carcinoma. A Phase II study of the Hellenic Cooperative Oncology Group.

Bamias A, Moulopoulos LA, Koutras A, Aravantinos G, Fountzilas G, Pectasides D, Kastritis E, Gika D, Skarlos D, Linardou H, Kalofonos HP, Dimopoulos MA. Bamias A, et al. Cancer. 2006 Jan 15;106(2):297-303. doi: 10.1002/cncr.21604. Cancer. 2006. PMID: 16342065 Free article. Clinical Trial.

5

Intensified bimonthly cisplatin with bolus 5-fluorouracil, continuous 5-fluorouracil and high-dose leucovorin (LV5FU2) in Patients with advanced gastrointestinal carcinomas: a phase I dose-finding and pharmacokinetic study.

Bamias A, Syrigos K, Fountzilas G, Tzamakou E, Soulti K, Karavasilis V, Alamanos Y, Christodoulou C, Pavlidis N. Bamias A, et al. Am J Clin Oncol. 2004 Oct;27(5):465-71. doi: 10.1097/01.coc.0000128870.72525.c7. Am J Clin Oncol. 2004. PMID: 15596912 Clinical Trial.

6

Mucinous but not clear cell histology is associated with inferior survival in patients with advanced stage ovarian carcinoma treated with platinum-paclitaxel chemotherapy.

Bamias A, Psaltopoulou T, Sotiropoulou M, Haidopoulos D, Lianos E, Bournakis E, Papadimitriou C, Rodolakis A, Vlahos G, Dimopoulos MA. Bamias A, et al. Cancer. 2010 Mar 15;116(6):1462-8. doi: 10.1002/cncr.24915. Cancer. 2010. PMID: 20108307 Free article.

7

Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.

Vassilakopoulou M, de la Motte Rouge T, Colin P, Ouzzane A, Khayat D, Dimopoulos MA, Papadimitriou CA, Bamias A, Pignot G, Nouhaud FX, Hurel S, Guy L, Bigot P, Roumiguié M, Rouprêt M; French Collaborative National Database on UUT-UCC. Vassilakopoulou M, et al. Cancer. 2011 Dec 15;117(24):5500-8. doi: 10.1002/cncr.26172. Epub 2011 Jun 2. Cancer. 2011. PMID: 21638278 Free article.

8

Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.

Dimopoulos MA, Papadimitriou C, Hamilos G, Efstathiou E, Vlahos G, Rodolakis A, Aravantinos G, Kalofonos H, Kouroussis C, Gika D, Skarlos D, Bamias A. Dimopoulos MA, et al. Gynecol Oncol. 2004 Dec;95(3):695-700. doi: 10.1016/j.ygyno.2004.08.018. Gynecol Oncol. 2004. PMID: 15581984 Clinical Trial.

9

Prognostic significance of cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma treated with first-line sunitinib: a European multiinstitutional study.

Bamias A, Tzannis K, Papatsoris A, Oudard S, Beuselinck B, Escudier B, Liontos M, Elaidi TR, Chrisofos M, Stravodimos K, Anastasiou I, Mitropoulos D, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamia C. Bamias A, et al. Clin Genitourin Cancer. 2014 Oct;12(5):373-83. doi: 10.1016/j.clgc.2014.03.012. Epub 2014 Mar 27. Clin Genitourin Cancer. 2014. PMID: 24819319

10

Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.

Bamias A, Papadimitriou C, Efstathiou E, Rodolakis A, Vlahos G, Voulgaris Z, Bozas G, Fountzilas G, Aravantinos G, Razis E, Gika D, Dimopoulos MA. Bamias A, et al. BMC Cancer. 2006 Sep 25;6:228. doi: 10.1186/1471-2407-6-228. BMC Cancer. 2006. PMID: 16999858 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page